Bristol-Myers Squibb Stock: A Strong Buy Amid Oncology Success
Bristol-Myers Squibb released financial results for Q4 2024. Check out why I am upgrading BMY stock's rating from 'Buy' to ...
stocknews1d
3 Precision Medicine Stocks That Could Transform Healthcare
With the robust demand for personalized medicines and the growing adoption of digital technology, the precision medicine ...
STAT1d
An awkward moment for Pfizer’s Bourla in Washington
The future of the CDC’s vaccine advisory committee seems uncertain: A scheduled February meeting for the ACIP, which advises ...
Insider Monkey14d
Why Legend Biotech Corporation (LEGN) Is Among the Best Healthcare Stocks To Buy According to Analysts
We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where Legend Biotech Corporation (NASDAQ:LEGN ...
Taiwan News15d
PharmAla Signs Advisory Agreement with Mr. Matthew Azrieli
TORONTO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and ...
ETF Daily News15d
Promising Biotech Stocks To Follow Today – February 05th
AbbVie, Danaher, Vertex Pharmaceuticals, Cencora, GSK, Thermo Fisher Scientific, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat’s stock screener tool.
Investing15d
Earnings call transcript: Pharmala Biotech Q1 2024 sees 95% revenue growth
Pharmala Biotech Holdings Inc. (market cap ... also highlighted strategic partnerships and operational efficiencies. The stock has shown remarkable momentum, surging 200% over the past six months to ...